Daniel Röshammar
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 8
- Virology 4
- HIV Research and Treatment 4
- Co-authors
- Michael Ashton (11 shared papers)Jackson Mukonzo (3 shared papers)Emmanuel Chigutsa (1 shared paper)Charles F. B. Nhachi (1 shared paper)Prosper Chonzi (1 shared paper)Collen Masimirembwa (1 shared paper)Dinko Rekić (5 shared papers)Jasper Ogwal‐Okeng (2 shared papers)
- Journals
- Journal of Pharmacokinetics and Pharmacodynamics (4 papers)British Journal of Clinical Pharmacology (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)European Journal of Clinical Pharmacology (2 papers)The AAPS Journal (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Daniel Röshammar
22 papers receiving 558 citations
Peers
Comparison fields: 5 of 69
- Virology 84
- Infectious Diseases 221
- Pharmacology 97
- Internal Medicine 13
- Public Health, Environmental and Occupational Health 87
Countries citing papers authored by Daniel Röshammar
This map shows the geographic impact of Daniel Röshammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Röshammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Röshammar more than expected).
Fields of papers citing papers by Daniel Röshammar
This network shows the impact of papers produced by Daniel Röshammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Röshammar. The network helps show where Daniel Röshammar may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Röshammar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 155 | |
| 2 | 2009 | 116 | |
| 3 | 2006 | 38 | |
| 4 | 2010 | 37 | |
| 5 | 2007 | 37 | |
| 6 | 2017 | 31 | |
| 7 | 2011 | 26 | |
| 8 | 2012 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 15 | |
| 11 | 2016 | 14 | |
| 12 | 2016 | 13 | |
| 13 | 2018 | 12 | |
| 14 | 2011 | 11 | |
| 15 | 2023 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2013 | 6 | |
| 18 | 2016 | 3 | |
| 19 | 2011 | 3 | |
| 20 | 2012 | 3 |
About Daniel Röshammar
Daniel Röshammar is a scholar working on Infectious Diseases, Virology, Organic Chemistry, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 574 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (4 papers), Chemical synthesis and alkaloids (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Psychedelics and Drug Studies (3 papers), Ovarian function and disorders (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Virology (84 citations), Infectious Diseases (221 citations), Pharmacology (97 citations), Internal Medicine (13 citations) and Public Health, Environmental and Occupational Health (87 citations). Daniel Röshammar has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Michael Ashton, Jackson Mukonzo, Emmanuel Chigutsa, Charles F. B. Nhachi, Prosper Chonzi, Collen Masimirembwa, Dinko Rekić, Jasper Ogwal‐Okeng, Lars L. Gustafsson and Eleni Aklillu. Their work appears in journals such as Journal of Pharmacokinetics and Pharmacodynamics, British Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology, European Journal of Clinical Pharmacology and The AAPS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.